Erythroblastic transformation of chronic myelogenous leukemia associated with an additional chromosome abnormality translocation (6;9

N. Awaya, M. Takao, H. Natsuda, T. Yamawaki, N. Suzuki, N. Takayama, A. Ishida, Y. Kawai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 57-year-old female was diagnosed being in the blastic phase of chronic myelogenous leukemia (CML) on her second admission in May 1993. The patient was previously treated with vincristine and prednisolone in the accelerated phase of CML in December 1991 without improvement. Other chemotherapeutic agents such as BHAC-DMP (enocitabine, daunorubicin, mercaptopurine, prednisolone), interferon, mercaptopurine and ranimustine were also administered. After the second chronic phase was achieved, she was treated with busulfan as an outpatient. On her second admission, the diagnosis of erythroblastic transformation was made, and cytogenetic study revealed t(9;22) (q34;q11) with the additional chromosomal abnormalities, t(6;9) (p23;q34). This karyotype rearrangement has been reported neither in Ph-positive CML nor in blastic crisis.

Original languageEnglish
Pages (from-to)1300-1304
Number of pages5
Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
Volume36
Issue number11
Publication statusPublished - 1995 Nov
Externally publishedYes

Fingerprint

Leukemia, Myeloid, Chronic Phase
6-Mercaptopurine
enocitabine
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Prednisolone
Chromosome Aberrations
Busulfan
Daunorubicin
Vincristine
Karyotype
Cytogenetics
Interferons
Outpatients
ranimustine

Cite this

Erythroblastic transformation of chronic myelogenous leukemia associated with an additional chromosome abnormality translocation (6;9. / Awaya, N.; Takao, M.; Natsuda, H.; Yamawaki, T.; Suzuki, N.; Takayama, N.; Ishida, A.; Kawai, Y.

In: [Rinshō ketsueki] The Japanese journal of clinical hematology, Vol. 36, No. 11, 11.1995, p. 1300-1304.

Research output: Contribution to journalArticle

Awaya, N, Takao, M, Natsuda, H, Yamawaki, T, Suzuki, N, Takayama, N, Ishida, A & Kawai, Y 1995, 'Erythroblastic transformation of chronic myelogenous leukemia associated with an additional chromosome abnormality translocation (6;9', [Rinshō ketsueki] The Japanese journal of clinical hematology, vol. 36, no. 11, pp. 1300-1304.
Awaya, N. ; Takao, M. ; Natsuda, H. ; Yamawaki, T. ; Suzuki, N. ; Takayama, N. ; Ishida, A. ; Kawai, Y. / Erythroblastic transformation of chronic myelogenous leukemia associated with an additional chromosome abnormality translocation (6;9. In: [Rinshō ketsueki] The Japanese journal of clinical hematology. 1995 ; Vol. 36, No. 11. pp. 1300-1304.
@article{0b58d51e4a584d69a7cae5473b566e57,
title = "Erythroblastic transformation of chronic myelogenous leukemia associated with an additional chromosome abnormality translocation (6;9",
abstract = "A 57-year-old female was diagnosed being in the blastic phase of chronic myelogenous leukemia (CML) on her second admission in May 1993. The patient was previously treated with vincristine and prednisolone in the accelerated phase of CML in December 1991 without improvement. Other chemotherapeutic agents such as BHAC-DMP (enocitabine, daunorubicin, mercaptopurine, prednisolone), interferon, mercaptopurine and ranimustine were also administered. After the second chronic phase was achieved, she was treated with busulfan as an outpatient. On her second admission, the diagnosis of erythroblastic transformation was made, and cytogenetic study revealed t(9;22) (q34;q11) with the additional chromosomal abnormalities, t(6;9) (p23;q34). This karyotype rearrangement has been reported neither in Ph-positive CML nor in blastic crisis.",
author = "N. Awaya and M. Takao and H. Natsuda and T. Yamawaki and N. Suzuki and N. Takayama and A. Ishida and Y. Kawai",
year = "1995",
month = "11",
language = "English",
volume = "36",
pages = "1300--1304",
journal = "[Rinshō ketsueki] The Japanese journal of clinical hematology",
issn = "0485-1439",
publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",
number = "11",

}

TY - JOUR

T1 - Erythroblastic transformation of chronic myelogenous leukemia associated with an additional chromosome abnormality translocation (6;9

AU - Awaya, N.

AU - Takao, M.

AU - Natsuda, H.

AU - Yamawaki, T.

AU - Suzuki, N.

AU - Takayama, N.

AU - Ishida, A.

AU - Kawai, Y.

PY - 1995/11

Y1 - 1995/11

N2 - A 57-year-old female was diagnosed being in the blastic phase of chronic myelogenous leukemia (CML) on her second admission in May 1993. The patient was previously treated with vincristine and prednisolone in the accelerated phase of CML in December 1991 without improvement. Other chemotherapeutic agents such as BHAC-DMP (enocitabine, daunorubicin, mercaptopurine, prednisolone), interferon, mercaptopurine and ranimustine were also administered. After the second chronic phase was achieved, she was treated with busulfan as an outpatient. On her second admission, the diagnosis of erythroblastic transformation was made, and cytogenetic study revealed t(9;22) (q34;q11) with the additional chromosomal abnormalities, t(6;9) (p23;q34). This karyotype rearrangement has been reported neither in Ph-positive CML nor in blastic crisis.

AB - A 57-year-old female was diagnosed being in the blastic phase of chronic myelogenous leukemia (CML) on her second admission in May 1993. The patient was previously treated with vincristine and prednisolone in the accelerated phase of CML in December 1991 without improvement. Other chemotherapeutic agents such as BHAC-DMP (enocitabine, daunorubicin, mercaptopurine, prednisolone), interferon, mercaptopurine and ranimustine were also administered. After the second chronic phase was achieved, she was treated with busulfan as an outpatient. On her second admission, the diagnosis of erythroblastic transformation was made, and cytogenetic study revealed t(9;22) (q34;q11) with the additional chromosomal abnormalities, t(6;9) (p23;q34). This karyotype rearrangement has been reported neither in Ph-positive CML nor in blastic crisis.

UR - http://www.scopus.com/inward/record.url?scp=0029401550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029401550&partnerID=8YFLogxK

M3 - Article

C2 - 8691572

AN - SCOPUS:0029401550

VL - 36

SP - 1300

EP - 1304

JO - [Rinshō ketsueki] The Japanese journal of clinical hematology

JF - [Rinshō ketsueki] The Japanese journal of clinical hematology

SN - 0485-1439

IS - 11

ER -